Consolidated Statement Of Income

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7586092

Concept 2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2021-04-01 to
2021-09-30
2021-04-01 to
2021-09-30
2021-04-01 to
2021-09-30
2021-04-01 to
2021-09-30
2021-04-01 to
2021-09-30
2021-04-01 to
2021-09-30
Consolidated statement of income
Statement of income
Net sales
3,234,000,000 JPY
26,851,000,000 JPY
-28,000,000 JPY
114,000,000 JPY
30,200,000,000 JPY
30,172,000,000 JPY
28,504,000,000 JPY
93,000,000 JPY
-26,000,000 JPY
28,477,000,000 JPY
2,791,000,000 JPY
25,619,000,000 JPY
Ordinary income
Other operating income
Share of profit of entities accounted for using equity method
JPY
51,000,000 JPY
Operating expenses
Selling, general and administrative expenses
11,422,000,000 JPY
10,768,000,000 JPY
Operating expenses
Cost of sales
15,870,000,000 JPY
15,051,000,000 JPY
Gross profit (loss)
14,301,000,000 JPY
13,426,000,000 JPY
Ordinary profit (loss)
2,987,000,000 JPY
2,743,000,000 JPY
Operating profit (loss)
231,000,000 JPY
3,141,000,000 JPY
-473,000,000 JPY
-20,000,000 JPY
3,352,000,000 JPY
2,879,000,000 JPY
3,000,000,000 JPY
-26,000,000 JPY
-342,000,000 JPY
2,657,000,000 JPY
229,000,000 JPY
2,797,000,000 JPY
Net sales
Operating expenses
Research and development expenses
1,768,000,000 JPY
1,941,000,000 JPY
Cost of sales
Non-operating income
236,000,000 JPY
254,000,000 JPY
Dividend income
185,000,000 JPY
137,000,000 JPY
Interest income
0 JPY
0 JPY
Selling, general and administrative expenses
Non-operating income
Other
51,000,000 JPY
65,000,000 JPY
Extraordinary income
32,000,000 JPY
JPY
Non-operating expenses
Interest expenses
25,000,000 JPY
29,000,000 JPY
Other
75,000,000 JPY
30,000,000 JPY
Non-operating expenses
128,000,000 JPY
168,000,000 JPY
Extraordinary losses
JPY
6,882,000,000 JPY
Impairment losses
JPY
5,921,000,000 JPY
Other
JPY
961,000,000 JPY
Profit (loss) before income taxes
3,019,000,000 JPY
-4,139,000,000 JPY
Gross profit
Extraordinary income
Gain on sale of investment securities
32,000,000 JPY
JPY
Income taxes - current
693,000,000 JPY
117,000,000 JPY
Extraordinary losses
Income taxes - deferred
-19,000,000 JPY
-1,460,000,000 JPY
Income taxes
673,000,000 JPY
-1,342,000,000 JPY
Profit (loss)
2,346,000,000 JPY
-2,796,000,000 JPY
Profit (loss) attributable to owners of parent
2,346,000,000 JPY
-2,796,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
519,000,000 JPY
162,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
371,000,000 JPY
59,000,000 JPY
Remeasurements of defined benefit plans, net of tax
13,000,000 JPY
15,000,000 JPY
Other comprehensive income
905,000,000 JPY
237,000,000 JPY
Profit attributable to
Comprehensive income
3,251,000,000 JPY
-2,559,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
3,251,000,000 JPY
-2,559,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.